These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28627471)

  • 1. Phospholipid-drug conjugates as a novel oral drug targeting approach for the treatment of inflammatory bowel disease.
    Dahan A; Markovic M; Epstein S; Cohen N; Zimmermann EM; Aponick A; Ben-Shabat S
    Eur J Pharm Sci; 2017 Oct; 108():78-85. PubMed ID: 28627471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational modeling and in-vitro/in-silico correlation of phospholipid-based prodrugs for targeted drug delivery in inflammatory bowel disease.
    Dahan A; Markovic M; Keinan S; Kurnikov I; Aponick A; Zimmermann EM; Ben-Shabat S
    J Comput Aided Mol Des; 2017 Nov; 31(11):1021-1028. PubMed ID: 29101519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipid-Based Prodrugs for Colon-Targeted Drug Delivery: Experimental Study and In-Silico Simulations.
    Markovic M; Dahan A; Keinan S; Kurnikov I; Aponick A; Zimmermann EM; Ben-Shabat S
    Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30995772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA
    Markovic M; Abramov-Harpaz K; Regev C; Ben-Shabat S; Aponick A; Zimmermann EM; Miller Y; Dahan A
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid-Based Prodrugs for Drug Targeting in Inflammatory Bowel Disease: Computational Optimization and In-Vitro Correlation.
    Dahan A; Ben-Shabat S; Cohen N; Keinan S; Kurnikov I; Aponick A; Zimmermann EM
    Curr Top Med Chem; 2016; 16(23):2543-8. PubMed ID: 27086789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLA
    Markovic M; Ben-Shabat S; Nagendra Manda J; Abramov-Harpaz K; Regev C; Miller Y; Aponick A; Zimmermann EM; Dahan A
    Pharmaceutics; 2022 Mar; 14(3):. PubMed ID: 35336048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid Cyclosporine Prodrugs Targeted at Inflammatory Bowel Disease (IBD) Treatment: Design, Synthesis, and in Vitro Validation.
    Manda JN; Markovic M; Zimmermann EM; Ben-Shabat S; Dahan A; Aponick A
    ChemMedChem; 2020 Sep; 15(17):1639-1644. PubMed ID: 32618133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diclofenac-β-cyclodextrin for colonic drug targeting: In vivo performance in rats.
    Vieira AC; Serra AC; Veiga FJ; Gonsalves AM; Basit AW; Murdan S
    Int J Pharm; 2016 Mar; 500(1-2):366-70. PubMed ID: 26784980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prodrug approach involving in situ depot formation to achieve localized and sustained action of diclofenac after joint injection.
    Thing M; Ågårdh L; Larsen S; Rasmussen R; Pallesen J; Mertz N; Kristensen J; Hansen M; Østergaard J; Larsen CS
    J Pharm Sci; 2014 Dec; 103(12):4021-4029. PubMed ID: 25354787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mechanism for oral controlled release of drugs by continuous degradation of a phospholipid prodrug along the intestine: in-vivo and in-vitro evaluation of an indomethacin-lecithin conjugate.
    Dahan A; Duvdevani R; Dvir E; Elmann A; Hoffman A
    J Control Release; 2007 May; 119(1):86-93. PubMed ID: 17382425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
    El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI
    Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipidic prodrug approach for improved oral drug delivery and therapy.
    Markovic M; Ben-Shabat S; Keinan S; Aponick A; Zimmermann EM; Dahan A
    Med Res Rev; 2019 Mar; 39(2):579-607. PubMed ID: 30320896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrospun poly-l-lactide scaffold for the controlled and targeted delivery of a synthetically obtained Diclofenac prodrug to treat actinic keratosis.
    Piccirillo G; Bochicchio B; Pepe A; Schenke-Layland K; Hinderer S
    Acta Biomater; 2017 Apr; 52():187-196. PubMed ID: 27816622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Acting Diclofenac Ester Prodrugs for Joint Injection: Kinetics, Mechanism of Degradation, and In Vitro Release From Prodrug Suspension.
    Mertz N; Larsen SW; Kristensen J; Østergaard J; Larsen C
    J Pharm Sci; 2016 Oct; 105(10):3079-3087. PubMed ID: 27475785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Modeling-Guided Design of Phospholipid-Based Prodrugs.
    Markovic M; Ben-Shabat S; Keinan S; Aponick A; Zimmermann EM; Dahan A
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31060339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of a nonsteroidal anti-inflammatory polymeric prodrug for sustained and site-specific delivery.
    Chandrasekar MJ; Ravichandran M; Nanjan MJ; Suresh B
    Drug Dev Ind Pharm; 2001 Oct; 27(9):959-64. PubMed ID: 11763474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart Responsive Quercetin-Conjugated Glycol Chitosan Prodrug Micelles for Treatment of Inflammatory Bowel Diseases.
    Shen C; Zhao L; Du X; Tian J; Yuan Y; Jia M; He Y; Zeng R; Qiao R; Li C
    Mol Pharm; 2021 Mar; 18(3):1419-1430. PubMed ID: 33522827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution.
    Singh N; Jabeen T; Sharma S; Somvanshi RK; Dey S; Srinivasan A; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):410-6. PubMed ID: 16552142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel diclofenac-hydrogel conjugate system for intraarticular sustained release: Development of 2-pyridylamino-substituted 1-phenylethanol (PAPE) and its derivatives as tunable traceless linkers.
    Kawanami T; LaBonte LR; Amin J; Thibodeaux SJ; Lee CC; Argintaru OA; Adams CM
    Int J Pharm; 2020 Jul; 585():119519. PubMed ID: 32535069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aceclofenac-Galactose Conjugate: Design, Synthesis, Characterization, and Pharmacological and Toxicological Evaluations.
    Magliocca S; De Caro C; Lazzarato L; Russo R; Rolando B; Chegaev K; Marini E; Nieddu M; Burrai L; Boatto G; Cristiano C; Marabello D; Gazzano E; Riganti C; Sodano F; Rimoli MG
    Mol Pharm; 2018 Aug; 15(8):3101-3110. PubMed ID: 29912563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.